Cathay Biotech Inc. (SHA:688065)

Market Cap	39.48B
Revenue (ttm)	3.18B
Net Income (ttm)	550.18M
Shares Out	720.66M
EPS (ttm)	0.89
PE Ratio	61.32
Forward PE	60.20
Dividend	0.40 (0.72%)
Ex-Dividend Date	Aug 1, 2025

Volume	3,485,434
Average Volume	5,679,814
Open	54.20
Previous Close	54.78
Day's Range	54.04 - 55.29
52-Week Range	32.48 - 56.98
Beta	0.62
RSI	59.30
Earnings Date	Aug 16, 2025

About Cathay Biotech

Cathay Biotech Inc., a bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. It offers biological long-chain diacids comprising sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine. The products are used in various applications, including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, and other industries. It provides its products under the TERRYL and ECOPENT brands. Cathay Biotech In...

• Industry: Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 1,735
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688065

Financial Performance

In 2024, Cathay Biotech's revenue was 2.96 billion, an increase of 39.91% compared to the previous year's 2.11 billion. Earnings were 488.96 million, an increase of 33.41%.